Posted Dec. 10, 2012 at 7:15 a.m.

Premium Lock GSK strikes $335M drug deal with Texas cancer center

Published: 2012-12-10 07:15:00
Updated: 2012-12-10 07:15:00

Cancer research  Cancer research Image 1 of 2 · Next Image…

GlaxoSmithKline signs a research and development deal with the MD Anderson Cancer Center in Texas that will focus on using the body's immune system to fight cancer. The deal could be worth $335 million plus royalties....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders